In NA (nucleoside analog) treatment, exacerbations are encountered through increased ALT, gastrointestinal distress, asthenia, headache, peripheral neuropathy, lactic acidosis, pancreatitis, and myalgia [21]. The gene discussed is GPT; the disease is peripheral neuropathy.